MFLRC - MF License & Regulatory Consultants

July 14, 2026 · Compliance

Health Canada Personal and Designated Medical Cannabis Crackdown: What Producers and Applicants Need to Know

By Mussarat Fatima

ComplianceRegulations
Health Canada Personal and Designated Medical Cannabis Crackdown: What Producers and Applicants Need to Know

Health Canada is tightening its grip on personal and designated production of cannabis for medical purposes, and the numbers now confirm it. In fiscal year 2024-25, the department completed 197 inspections of these registrations, rated 93 of them at the most severe level, and revoked or refused 50 registrations based on that single year of inspections. Since the Cannabis Act came into force in 2018, more than 5,600 registrations have been refused or revoked across the country.

For medical registrants, licensed producers, and anyone considering a commercial application, this is not a quiet administrative trend. It is a coordinated, risk-based enforcement push that Health Canada has now documented in its own compliance reports and in a formal response to Parliament. This article breaks down what is actually happening, where the data comes from, and what regulated businesses should do to protect themselves.

Executive Summary

Health Canada oversees roughly 10,000 active personal and designated production registrations for medical cannabis, allowing individuals to grow cannabis for their own medical use or to designate someone to grow it for them. Concern about diversion to the illegal market, high daily authorized amounts, and residential safety hazards has driven a steady escalation in inspections and revocations.

Key figures, drawn from Health Canada's Compliance and Enforcement Report for 2024-25 and from the government's April 2026 response to House of Commons Written Question Q-933, include the following: 197 personal and designated inspections in 2024-25, 93 rated level 3 (most severe), 50 registrations revoked or refused from that year's inspections, and more than 5,600 refused or revoked since 2018. On the commercial side, Health Canada had revoked 29 commercial cannabis licences as of January 31, 2026. The department applies a risk-based model that prioritizes high plant counts, multiple registrations at one site, and complaints from the public or law enforcement.

The takeaway for industry: scrutiny is rising on both the personal and designated framework and the commercial licensing stream. Robust documentation, honest applications, and inspection readiness are now essential.

What Is Personal and Designated Production of Medical Cannabis?

Personal and designated production registrations allow an individual with a medical document from a health care practitioner to produce a limited amount of cannabis for their own medical purposes, or to designate another person to produce it on their behalf. This framework sits within the Cannabis Act and the Cannabis Regulations (SOR/2018-144), and it is separate from the commercial licensing stream that governs licensed producers.

Why it matters: these registrations are not commercial licences, yet some authorize very large plant counts in residential settings. Health Canada sets the maximum number of plants using a formula tied to the daily amount of dried cannabis a health care practitioner authorizes. Higher daily amounts translate into more plants, and a small share of registrations authorize amounts high enough to permit more than 100 indoor plants.

What companies and applicants should understand: the personal and designated stream has become a focal point for diversion concerns. Even legitimate registrants can attract inspection attention if their site carries a high plant count, hosts multiple registrations, or draws complaints. Understanding the difference between this framework and a commercial licence is the first step toward staying compliant, and it is often the trigger for businesses to consider transitioning to a properly structured micro cultivation or micro processing licence.

The Data: What Health Canada's Own Reports Show

Health Canada publishes annual cannabis inspection data, and the 2024-25 report is the authoritative record of enforcement activity. It is the real source behind the headlines, not a secondary summary.

In fiscal year 2024-25 (April 1, 2024 to March 31, 2025), Health Canada conducted 889 inspections in total under the Cannabis Act and its regulations. Of those, 197 were inspections of registered personal and designated production of cannabis for medical purposes. The geographic concentration is striking: 99 inspections in British Columbia, 74 in Ontario, 19 in Quebec, and 5 in Alberta.

The inspection ratings tell the compliance story clearly.

Inspection outcome (2024-25)Personal and designated production
Total inspections197
Level 3 rating (most severe)93
Level 2 rating56
Level 1 rating37
Not rated11
Registrations revoked or refused (from these inspections, to date)50

Nearly half of all personal and designated inspections received the most severe rating. That is a high non-compliance signal, and it explains why enforcement has escalated. Health Canada also noted that additional actions from these inspections are ongoing or under consideration, so the 50 revocations or refusals may rise. For context on how often regulators inspect the sector and what triggers a visit, see our guide on how often cannabis companies get audited.

Why the Crackdown Is Happening

The escalation is deliberate and reflects long-standing concerns about diversion and public safety. Understanding the drivers helps registrants and applicants anticipate scrutiny.

Health Canada has stated that it uses a risk-based approach rather than a fixed inspection schedule. Instead of inspecting every site on a set calendar, the department prioritizes cases that present the highest risk. According to the government's response to Written Question Q-933, the priorities are clear.

  • High plant counts. Registrations authorizing large daily amounts, and therefore large numbers of plants, receive closer attention.
  • Multiple registrations at one site. Several registrations clustered at a single address raise diversion and safety concerns.
  • Complaints. Over the past five years, Health Canada received 463 complaints, which led to 35 inspections and 15 enforcement actions.

The context is diversion to the illegal market. Provincial police, including the Ontario Provincial Police, have publicly stated that criminal enterprises exploit the personal and designated framework to produce cannabis for illicit sale. Municipalities have raised concerns about odour, fire safety, and large-scale grows in residential neighbourhoods. Health Canada has responded by strengthening oversight of the medical framework while pointing to provincial and municipal authorities as the primary regulators of zoning and building safety.

The Royal Canadian Mounted Police, according to the Minister of Public Safety's response, do not routinely monitor compliance with these registrations. Their involvement is generally incidental to other police investigations. That places the compliance burden squarely on Health Canada's inspection program.

The Commercial Licensing Angle: Slower Approvals, More Revocations

The tightening is not limited to personal and designated growers. Commercial applicants and licence holders are also facing a more demanding environment.

As of January 31, 2026, Health Canada had revoked 29 commercial cannabis licences since 2018. Of these, 15 were revoked because the licence holder failed to pay the annual regulatory fee, and 14 were revoked for other non-compliance. That split is a useful reminder: a licence can be lost for a straightforward administrative failure just as easily as for a serious quality or security breach.

At the same time, new commercial licence approvals have slowed while the department focuses resources on compliance and enforcement. For applicants, this means longer timelines, tighter review, and a lower tolerance for incomplete or inconsistent files. Businesses that once viewed the personal and designated route as a shortcut should recognize that the compliant path to producing cannabis for sale runs through a commercial licence, most often a micro cultivation or micro processing licence, backed by Good Production Practices and a qualified quality assurance function. Getting the licensing pathway and submission strategy right from the start is now more important than ever.

What This Means for Compliance

Direct answer: the crackdown raises the practical risk of losing a registration or licence, and it rewards businesses that can demonstrate control through documentation, security, and honest reporting. Regulators are acting on data, and they expect registrants and licence holders to do the same.

For personal and designated registrants, compliance means staying within authorized plant limits, keeping the medical document valid and current, maintaining safe growing conditions, and being ready for an inspection that can be triggered by a single complaint. For commercial licence holders, it means treating Good Production Practices, recordkeeping, security, and fee payment as non-negotiable. For applicants, it means submitting a complete, internally consistent file that survives close review.

The common thread is evidence. Health Canada's enforcement is graduated and proportional, which means the quality of your documentation and your ability to correct issues quickly can be the difference between a corrective action letter and a revocation.

Compliance Checklist: Reducing Your Revocation Risk

Use this checklist as a starting point for a self-assessment. It applies to registrants, licence holders, and applicants in different ways, but every item reflects a real Health Canada focus area.

  • Confirm that your authorized plant count matches what you actually grow, indoors and outdoors.
  • Keep the underlying medical document valid, current, and on file.
  • Ensure only one registration operates at a residential site unless every additional registration is fully documented and lawful.
  • Maintain security measures appropriate to the scale of production.
  • Address odour, mould, electrical, and fire safety risks before they generate complaints.
  • Keep complete production, inventory, and destruction records that reconcile with one another.
  • For commercial licence holders, pay the annual regulatory fee on time, every time.
  • Document your Good Production Practices and assign clear quality assurance responsibility.
  • Prepare an inspection readiness file so you can respond quickly to an onsite or offsite inspection.
  • Have a corrective and preventive action (CAPA) process ready to close findings before they escalate.

Common Mistakes That Trigger Enforcement

Learning from the patterns in Health Canada's inspection findings is one of the most effective ways to avoid becoming a statistic. The 2024-25 report and prior years point to recurring problems.

  • Exceeding authorized limits. Growing more plants than the registration allows is a direct and easily verified breach.
  • Poor recordkeeping. Unsatisfactory retention of documents and information is one of the most cited findings across cannabis inspections.
  • Weak security. Insufficient safekeeping and access control invite diversion concerns and severe ratings.
  • Ignoring complaints and nuisance issues. Odour and safety complaints from neighbours frequently trigger the inspections that lead to revocation.
  • Treating personal and designated production as a commercial workaround. Using a medical registration to supply the market is exactly the abuse regulators are targeting.
  • Missing the annual fee. On the commercial side, more than half of revocations since 2018 stemmed from unpaid regulatory fees.

Frequently Asked Questions

How many medical cannabis registrations has Health Canada revoked?

Since the Cannabis Act came into force in 2018, more than 5,600 personal and designated production registrations have been refused or revoked, with the vast majority cited for public health and public safety risks. In fiscal year 2024-25 alone, 50 registrations were revoked or refused based on that year's inspections.

What triggers a Health Canada inspection of a personal or designated grow?

Health Canada uses a risk-based approach that prioritizes high plant counts, multiple registrations at a single site, and complaints from the public or law enforcement. There is no fixed inspection schedule, so any of these factors can prompt an onsite or offsite inspection.

How many active personal and designated registrations exist in Canada?

As of early 2026, there were nearly 10,000 active personal and designated production registrations nationwide. Quebec led with about 3,049, followed by Ontario with about 2,507 and British Columbia with about 2,500.

Can I use a personal or designated registration to sell cannabis?

No. These registrations authorize production for personal medical use only. Diverting cannabis grown under a personal or designated registration to the illegal market is precisely the abuse Health Canada is targeting. Selling cannabis legally requires a commercial licence under the Cannabis Regulations.

What is the difference between a personal registration and a commercial cannabis licence?

A personal or designated registration lets an individual grow a limited amount for their own medical purposes. A commercial licence authorizes activities such as cultivation, processing, and sale, and it carries Good Production Practices, security, quality assurance, and fee obligations. The two are governed differently and inspected differently.

Are commercial cannabis licences also being revoked?

Yes. As of January 31, 2026, Health Canada had revoked 29 commercial cannabis licences since 2018. Fifteen were revoked for failure to pay the annual regulatory fee and 14 for other non-compliance, so both administrative and substantive failures carry real risk.

How MFLRC Can Help

Navigating this environment takes more than good intentions. It takes a documented, defensible compliance system and a clear licensing strategy. MF License and Regulatory Consultants (MFLRC) works with registrants, licensed producers, and applicants across Canada to reduce regulatory risk and build files that hold up under Health Canada scrutiny.

Our team supports clients with gap assessments that measure your operation against current Cannabis Act and Cannabis Regulations requirements, standard operating procedure (SOP) development, and regulatory and licensing support for those transitioning from a personal or designated registration to a compliant micro cultivation or micro processing licence. We provide Quality Assurance Person (QAP) services and quality assurance support for Good Production Practices, along with audit and inspection readiness assessments, including mock audits and CAPA review, so an inspection does not catch you off guard. For a practical view of what inspectors expect, our guide on how to pass a Health Canada cannabis inspection walks through the six steps that matter most. For businesses expanding or correcting course, we deliver practical, senior-led advice rather than generic checklists.

If your registration carries a high plant count, if you have received a complaint or a compliance letter, or if you are planning a commercial application in a tighter approval climate, now is the time to get ahead of it.

Conclusion

Health Canada's enforcement data now tells a consistent story: inspections of personal and designated medical cannabis production are rising, severe ratings are common, and revocations are climbing. The primary sources, Health Canada's Compliance and Enforcement Report for 2024-25 and the government's response to Written Question Q-933, leave little room for doubt about the direction of travel. Commercial applicants and licence holders face the same message from a different angle: slower approvals and steady revocations.

The organizations that thrive in this climate will be the ones that treat compliance as a system, not a formality. Whether you hold a registration, operate under a commercial licence, or are preparing an application, the safest position is a documented, inspection-ready operation and an honest, complete file. MFLRC is here to help you build exactly that.

Sources and References

  • Health Canada, Compliance and enforcement report: Cannabis inspection data summary 2024-2025. canada.ca
  • House of Commons of Canada, Written Question Q-933 (Sessional Paper 8555-451-933), response tabled April 24, 2026. ourcommons.ca
  • Health Canada, Registering to produce cannabis for your own medical purposes. canada.ca
  • Health Canada, Compliance and enforcement policy for the Cannabis Act. canada.ca
  • Cannabis Regulations (SOR/2018-144), Justice Laws Website. laws-lois.justice.gc.ca
  • Health Canada, Data on cannabis for medical purposes. canada.ca
  • Health Canada, Data on commercial cannabis licence applications and licences. canada.ca

Share with others

Tags

CannabisHealth CanadaMedical CannabisComplianceInspection ReadinessCannabis Licensing
Book a consultation